论文部分内容阅读
慢性乙型肝炎(CHB)是由乙型肝炎病毒(HBV)引起的一种严重危害人类健康的病毒性传染病。抗病毒治疗成为目前CHB的首选治疗方法。目前已获美国食品与药品管理局(FDA)批准用于CHB治疗的核苷类似物包括拉米
Chronic hepatitis B (CHB) is a viral infection caused by Hepatitis B virus (HBV), which is a serious health hazard to human beings. Antiviral therapy has become the preferred treatment for CHB. Nucleoside analogs currently approved by the U.S. Food and Drug Administration (FDA) for CHB therapy include Lamy